Main Line Health

New Analysis Suggests Early Initiation of Multaq(R) (dronedarone) Feasible in AF Patients Following Discontinuation of Amiodarone

Older News

WYNNEWOOD, Pennsylvania, March 15, 2010 - Data from a post-hoc analysis presented today at the 59th Annual Scientific Session of the American College of Cardiology in Atlanta, Georgia, evaluated transition to Multaq(R) (dronedarone) in patients with atrial fibrillation (AF) or atrial flutter (AFL) following prior treatment with amiodarone.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy